(1)
Odierna, G. L.; Phillips, W. Targeting the Safety Factor for Neuromuscular Transmission to Treat Myasthenia Gravis: Safety Factor for Neuromuscular Transmission. rrnmf 2023, 4 (3). https://doi.org/10.17161/rrnmf.v4i3.19543.